Aref#d: 19109. Randomised Phase II Study of Amrubicin as Single Agent or in Combination with Cisplatin Versus Etoposide-Cisplatin as First-Line Treatment in Patients with Extensive Stage SCLC (ES)

  • Rankin, Elaine (Investigator)

    Project Details

    StatusFinished
    Effective start/end date23/11/0722/11/12

    Funding

    • European Organisation for Research and Treatment of Cancer (8062): £15,497.00